Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

被引:267
作者
Ezzet, F
van Vugt, M
Nosten, F
Looareesuwan, S
White, NJ
机构
[1] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10400, Thailand
[2] Novartis Pharma AG, Basel, Switzerland
[3] Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand
[4] Hosp Trop Dis, Bangkok, Thailand
[5] Univ Amsterdam, Acad Med Ctr, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands
[6] John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
D O I
10.1128/AAC.44.3.697-704.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The objective of this study was to conduct a prospective population pharmacokinetic and pharmacodynamic evaluation of lumefantrine during blinded comparisons of artemether-lumefantrine treatment regimens in uncomplicated multidrug-resistant falciparum malaria, Three combination regimens containing an average adult lumefantrine dose of 1,920 mg over 3 days (four doses) (regimen A) or 2,780 mg over 3 or 5 days (six doses) (regimen B or C, respectively) were given to 266 Thai patients. Detailed observations were obtained for 51 hospitalized adults, and sparse data were collected for 215 patients of all ages in a community setting. The population absorption half-life of lumefantrine was 4.5 h, The model-based median (5th and 95th percentiles) peak plasma lumefantrine concentrations were 6.2 (0.25 and 14.8) mu g/ml after regimen A, 9.0 (1.1 and 19.8) mu g/ml after regimen B, and 8 (1.4 and 17.4) mu g/ml after regimen C, During acute malaria, there was marked variability in the fraction of drug absorbed by patients (coefficient of variation, 150%). The fraction increased considerably and variability fell with clinical recovery, largely because food intake was resumed; taking a normal meal dose to drug administration increased oral bioavailability by 108% (90% confidence interval, 64 to 164) (P, 0.0001), The higher-dose regimens (B and C) gave 60 and 100% higher areas under the concentration-time curves (AUC), respectively, and thus longer durations for which plasma lumefantrine concentrations exceeded the putative in vivo MIC of 280 mu g/ml (median for regimen B, 252 h; that for regimen C, 298 h; that for regimen A, 204 h [P, 0.0001]) and higher cure rates. Lumefantrine oral bioavailability is very dependent on food and is consequently poor in acute malaria but improves markedly with recovery. The high cure rates with the two six-dose regimens resulted from increased AUC and increased time at which lumefantrine concentrations were above the in vivo MIC.
引用
收藏
页码:697 / 704
页数:8
相关论文
共 20 条
[11]   HALOFANTRINE VERSUS MEFLOQUINE IN TREATMENT OF MULTIDRUG-RESISTANT FALCIPARUM-MALARIA [J].
TERKUILE, FO ;
DOLAN, G ;
NOSTEN, F ;
EDSTEIN, MD ;
LUXEMBURGER, C ;
PHAIPUN, L ;
CHONGSUPHAJAISIDDHI, T ;
WEBSTER, HK ;
WHITE, NJ .
LANCET, 1993, 341 (8852) :1044-1049
[12]   The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol) [J].
van Vugt, M ;
Ezzet, F ;
Phaipun, L ;
Nosten, F ;
White, NJ .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (05) :564-565
[13]   Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria [J].
van Vugt, M ;
Brockman, A ;
Gemperli, B ;
Luxemburger, C ;
Gathmann, I ;
Royce, C ;
Slight, T ;
Looareesuwan, S ;
White, NJ ;
Nosten, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) :135-139
[14]   Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria [J].
van Vugt, M ;
Wilairatana, P ;
Gemperli, B ;
Gathmann, I ;
Phaipun, L ;
Brockman, A ;
Luxemburger, C ;
White, NJ ;
Nosten, F ;
Looareesuwan, S .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (06) :936-942
[15]  
VANVUGT M, 1999, IN PRESS AM J TROP M
[16]  
VONSEIDLEIN L, 1997, AM J TROP MED HYG, V56, P4494
[17]   Assessment of the pharmacodynamic properties of antimalarial drugs in vivo [J].
White, NJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1413-1422
[18]   CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF ARTEMISININ AND DERIVATIVES [J].
WHITE, NJ .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 :41-43
[19]   Preventing antimalarial drug resistance through combinations [J].
White, NJ .
DRUG RESISTANCE UPDATES, 1998, 1 (01) :3-9
[20]   Determination of benflumetol in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection [J].
Zeng, MY ;
Lu, ZL ;
Yang, SC ;
Zhang, M ;
Liao, J ;
Liu, SL ;
Teng, XH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 681 (02) :299-306